Model‐based meta‐analysis of the time to first acute urinary retention or benign prostatic hyperplasia‐related surgery in patients with moderate or severe symptoms

AIMS: Combination therapy of 5α‐reductase inhibitor and α‐blocker is a guideline‐endorsed therapeutic approach for patients with moderate‐to‐severe lower urinary tract symptoms or benign prostatic hyperplasia (LUTS/BPH) who are at risk of disease progression. We aimed to disentangle the contribution...

Descripción completa

Detalles Bibliográficos
Autores principales: D'Agate, Salvatore, Chavan, Chandrashekhar, Manyak, Michael, Palacios‐Moreno, Juan Manuel, Oelke, Matthias, Michel, Martin C., Roehrborn, Claus G., Della Pasqua, Oscar
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8359386/
https://www.ncbi.nlm.nih.gov/pubmed/33247951
http://dx.doi.org/10.1111/bcp.14682

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8359386/
https://www.ncbi.nlm.nih.gov/pubmed/33247951
http://dx.doi.org/10.1111/bcp.14682

Ejemplares similares